CAS: 117279-73-9
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Israpafant REF: 3D-SEA27973CAS: 117279-73-9 | Min. 95% | To inquire | Wed 18 Dec 24 |
 | Israpafant REF: TM-T27638CAS: 117279-73-9 | - - - | 2,206.00 €~3,920.00 € | Wed 05 Feb 25 |
Israpafant
Controlled ProductCAS:117279-73-9
Israpafant is a prodrug that is hydrolyzed to ertapenem, its active form. It inhibits bacterial …
Formula:
C28H29ClN4S
Purity:
Min. 95%
Molecular weight:
489.1 g/mol
Ref: 3D-SEA27973
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Wednesday 18 Dec 2024
Israpafant
CAS:117279-73-9
Israpafant: PAF receptor blocker, IC50 0.84nM, hinders platelet aggregation, eosinophil activation, boosts calcium transit, anti-nephrotoxic.
Formula:
C28H29ClN4S
Color and Shape:
Solid
Molecular weight:
489.07
Ref: TM-T27638
| 25mg | 2,206.00 € | ||
| 50mg | 2,899.00 € | ||
| 100mg | 3,920.00 € |
Estimated delivery in United States, on Wednesday 5 Feb 2025
